Dr. Ieva Saulite
Dermatologie | Venerologie | Allergologie · Dept. IV
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Zehnder M, Amarov B, Abrunhosa-Branquinho A, Maiwald-Urosevic M, Mühleisen B, Saulite I, Anzengruber F, Imhof L, Navarini A, Cozzio A, Dummer R, Dimitriou F, Guenova E. Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Dermatology 2022; 238:967-976.
14.02.2022Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
14.02.2022Dermatology 2022; 238:967-976
Zehnder Mara, Amarov Boyko, Abrunhosa-Branquinho André N, Maiwald-Urosevic Mirjana, Mühleisen Beda, Saulite Ieva, Anzengruber Florian, Imhof Laurence, Navarini Alexander A, Cozzio Antonio, Dummer Reinhard, Dimitriou Florentia, Guenova Emmanuella
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Pirker I, Saulite I, von Kempis J. Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus. ACR Open Rheumatol 2021; 3:41.
03.01.2021Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
03.01.2021ACR Open Rheumatol 2021; 3:41
Pirker Ian, Saulite Ieva, von Kempis Johannes
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Saulite I, Bobrowicz M, Hoetzenecker W, Pascolo S, Scarisbrick J, Dummer R, Cozzio A, Nägeli M, Anzengruber F, Varypataki E, Dimitriou F, Fassnacht C, Chang Y, Desislava I, Guenova E. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. Oncoimmunology 2020; 9:1738797.
18.03.2020Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
18.03.2020Oncoimmunology 2020; 9:1738797
Saulite Ieva, Bobrowicz Malgorzata, Hoetzenecker Wolfram, Pascolo Steve, Scarisbrick Julia, Dummer Reinhard, Cozzio Antonio, Nägeli Mirjam, Anzengruber Florian, Varypataki Eleni, Dimitriou Florentia, Fassnacht Christina, Chang Yun-Tsan, Desislava Ignatova, Guenova Emmanuella
[Warning symptoms skin: cutaneous manifestation of drug allergy]
Saulite I, Hötzenecker W, Cozzio A. [Warning symptoms skin: cutaneous manifestation of drug allergy]. Ther Umsch 2019; 75:43-48.
01.07.2019[Warning symptoms skin: cutaneous manifestation of drug allergy]
01.07.2019Ther Umsch 2019; 75:43-48
Saulite Ieva, Hötzenecker Wolfram, Cozzio Antonio
Pseudolymphomatous Reaction to Red Tattoo Pigment
Saulite I, Pekar-Lukacs A, Kerl K, Cozzio A, Hoetzenecker W, Guenova E. Pseudolymphomatous Reaction to Red Tattoo Pigment. Case Rep Dermatol 2018; 10:162-168.
14.06.2018Pseudolymphomatous Reaction to Red Tattoo Pigment
14.06.2018Case Rep Dermatol 2018; 10:162-168
Saulite Ieva, Pekar-Lukacs Agnes, Kerl Katrin, Cozzio Antonio, Hoetzenecker Wolfram, Guenova Emmanuella
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
Mangold A, Pittelkow M, Pujol R, Amitay-Laish I, Hodak E, Guenova E, Cozzio A, Saulite I, Davis M, Thompson A, Gniadecki R. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study. J Am Acad Dermatol 2017; 77:719-727.
11.07.2017Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
11.07.2017J Am Acad Dermatol 2017; 77:719-727
Mangold Aaron R, Pittelkow Mark R, Pujol Ramon M, Amitay-Laish Iris, Hodak Emmilia, Guenova Emmanuella, Cozzio Antonio, Saulite Ieva, Davis Mark D, Thompson Agnieszka K, Gniadecki Robert
Cutaneous Oncology: From Research to Diagnosis and Management
Saulite I, Roider E, Darlenksi R, Jalili A, Guenova E. Cutaneous Oncology: From Research to Diagnosis and Management. Biomed Res Int 2016; 2016:7819428.
02.06.2016Cutaneous Oncology: From Research to Diagnosis and Management
02.06.2016Biomed Res Int 2016; 2016:7819428
Saulite Ieva, Roider Elisabeth, Darlenksi Razvigor, Jalili Ahmad, Guenova Emmanuella
Toxic epidermal necrolysis
Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E, Cozzio A, French L. Toxic epidermal necrolysis. F1000Res 2016; 5
20.05.2016Toxic epidermal necrolysis
20.05.2016F1000Res 2016; 5
Hoetzenecker Wolfram, Mehra Tarun, Saulite Ieva, Glatz Martin, Schmid-Grendelmeier Peter, Guenova Emmanuella, Cozzio Antonio, French Lars E
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets. Biomed Res Int 2016; 2016:9717530.
17.05.2016Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
17.05.2016Biomed Res Int 2016; 2016:9717530
Saulite Ieva, Hoetzenecker Wolfram, Weidinger Stephan, Cozzio Antonio, Guenova Emmanuella, Wehkamp Ulrike
Expression of CD164 on Malignant T cells in Sézary Syndrome
Guenova E, Hoetzenecker W, French L, Kazakov D, Dummer R, Mitev V, Navarini A, Saulite I, Mehra T, Contassot E, Chang Y, Desislava I, Cozzio A. Expression of CD164 on Malignant T cells in Sézary Syndrome. Acta Derm Venereol 2016; 96:464-7.
01.05.2016Expression of CD164 on Malignant T cells in Sézary Syndrome
01.05.2016Acta Derm Venereol 2016; 96:464-7
Guenova Emmanuella, Hoetzenecker Wolfram, French Lars E, Kazakov Dmitry V, Dummer Reinhard, Mitev Vanyo, Navarini Alexander A, Saulite Ieva, Mehra Tarun, Contassot Emmanuel, Chang Yun-Tsan, Desislava Ignatova, Cozzio Antonio
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
Sönnichsen A, Cozzio A, Hoetzenecker W, Schmid-Grendelmeier P, Petrausch U, Chang Y, Desislava I, Mehra T, Kerl K, Mangana J, Saulite I, Guenova E. Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome. J Dermatolog Treat 2016; 27:436-8.
10.02.2016Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
10.02.2016J Dermatolog Treat 2016; 27:436-8
Sönnichsen Astrid, Cozzio Antonio, Hoetzenecker Wolfram, Schmid-Grendelmeier Peter, Petrausch Ulf, Chang Yun-Tsan, Desislava Ignatova, Mehra Tarun, Kerl Katrin, Mangana Johanna, Saulite Ieva, Guenova Emmanuella